Grant: Doctoral Award: Doctoral Foreign Study Award (DFSA)
Direct Payment
$120,000.00
Restructuring and Refining the Standard Model of RNA Thermodynamics Using Massively Parallelized Experiments, Quantitative Biochemical Analyses, and New Computational Modalities
EF 2024-25
Résumé
The advent of RNA-based therapeutics, including mRNA vaccines, transgenic RNAs, RNA interference (RNAi) therapies, antisense oligonucleotides (ASOs), and CRISPR-guided technologies, has marked a new era in precision medicine that heralds great promise for targeted treatments for a vast array of hitherto undruggable diseases. However, the efficacy and precision of any RNA medicine is affected by the dynamics and stabilities of the myriad structures RNA therapeutics and their targets adopt in different organs. As the importance of RNA design and engineering grows in the context of therapeutics, so grows the need for reliable and experimentally grounded models for predicting RNA conformations and on-target/off-target binding probabilities in biologically meaningful conditions. By leveraging our lab's massively parallelized RNA display imaging platform, we are gathering orders of magnitude more sequence-specific thermodynamic data than was previously possible, to quantify the conformational energies of RNA structural motifs. We will further test and extend these measurements by quantifying base pairing probabilities for appropriately re-designed variant libraries along several dimensions of buffer conditions and in cells with dimethyl sulfate mutational profiling and sequencing. These data will be used to train sophisticated yet interpretable computational models of RNA folding, spawning a new generation of informative tools fundamental to the study of all aspects of RNA biology, with diverse impacts on our understanding of the origins of life on Earth through to the development of safe and effective RNA medicines.
Programme
Doctoral Award: Doctoral Foreign Study Award (DFSA)
Bénéficiaire
Emplacement
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
516862
Name
Dunkley Owen
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Restructuring and Refining the Standard Model of RNA Thermodynamics Using Massively Parallelized Experiments, Quantitative Biochemical Analyses, and New Computational Modalities
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Award: Doctoral Foreign Study Award (DFSA)
Keyworddelim
Bioengineering; Computational Biology; Molecular Biology; Molecular Evolution; Nucleic Acid Biophysics; Pathogenesis And Treatment Of Diseases; Personalized Medicine; Quantitative Biochemistry; Sequencing Technologies; Virology
Abstract
The advent of RNA-based therapeutics, including mRNA vaccines, transgenic RNAs, RNA interference (RNAi) therapies, antisense oligonucleotides (ASOs), and CRISPR-guided technologies, has marked a new era in precision medicine that heralds great promise for targeted treatments for a vast array of hitherto undruggable diseases. However, the efficacy and precision of any RNA medicine is affected by the dynamics and stabilities of the myriad structures RNA therapeutics and their targets adopt in different organs. As the importance of RNA design and engineering grows in the context of therapeutics, so grows the need for reliable and experimentally grounded models for predicting RNA conformations and on-target/off-target binding probabilities in biologically meaningful conditions. By leveraging our lab's massively parallelized RNA display imaging platform, we are gathering orders of magnitude more sequence-specific thermodynamic data than was previously possible, to quantify the conformational energies of RNA structural motifs. We will further test and extend these measurements by quantifying base pairing probabilities for appropriately re-designed variant libraries along several dimensions of buffer conditions and in cells with dimethyl sulfate mutational profiling and sequencing. These data will be used to train sophisticated yet interpretable computational models of RNA folding, spawning a new generation of informative tools fundamental to the study of all aspects of RNA biology, with diverse impacts on our understanding of the origins of life on Earth through to the development of safe and effective RNA medicines.
Competitiondate
202410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Dunkley, Owen
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~